Pasar al contenido principal

MARCADORES DE NEUROIMAGEN DE LA ENFERMEDAD DE PARKINSON GENETICAMENTE DETERMINADA Y PARKINSONISMOS MEDIANTE SECUENCIAS DE RM DE NEUROMELANINA Y SWI DEL TRONCO DEL ENCEFALO

SAF2016-81016-R

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2016
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE NAVARRA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Brainstem neuromelanin and iron MRI reveals a precise signature for idiopathic and LRRK2 Parkinson's disease

  • Martínez, Martín|||0000-0002-3053-7920
  • Ariz, Mikel|||0000-0002-7328-1582
  • Alvarez, Ignacio|||0000-0002-8537-3935
  • Castellanos, Gabriel|||0000-0001-8121-1552
  • Aguilar, Miquel
  • Hernández-Vara, Jorge|||0000-0002-9129-5224
  • Caballol, Nuria|||0000-0003-3363-3077
  • Garrido, Alicia|||0000-0003-0652-6348
  • Bayés, Àngels|||0000-0001-9542-804X
  • Vilas Rolán, Dolores|||0000-0003-3084-053X
  • Martí Domenech, Maria Josep|||0000-0002-9872-7835
  • Pascual Sedano, Berta María|||0000-0002-9298-8241
  • Marín Lahoz, Juan|||0000-0003-0008-2360
  • Ávila, Asunción|||0000-0001-8357-0751
  • Buongiorno, Mariateresa
  • Tartari, Juan Pablo
  • Puente, Victor
  • Ezquerra, Mario|||0000-0003-3246-6641
  • Valldeoriola, Francesc|||0000-0002-8680-4274
  • Compta, Yaroslau|||0000-0001-6443-0104
  • Tolosa, Eduard|||0000-0001-6608-3038
  • Pont, Claustre
  • Pastor, Pau|||0000-0002-7493-8777
  • Ortiz de Solórzano, Carlos|||0000-0001-8720-0205
  • Pastor, Maria A.|||0000-0003-2404-9346
Neuromelanin (NM) loss in substantia nigra pars compacta (SNc) and locus coeruleus (LC) reflects neuronal death in Parkinson's disease (PD). Since genetically-determined PD shows varied clinical expressivity, we wanted to accurately quantify and locate brainstem NM and iron, to discover whether specific MRI patterns are linked to Leucine-rich repeat kinase 2 G2019S PD (LRRK2-PD) or idiopathic Parkinson's disease (iPD). A 3D automated MRI atlas-based segmentation pipeline (3D-ABSP) for NM/iron-sensitive MRI images topographically characterized the SNc, LC, and red nucleus (RN) neuronal loss and calculated NM/iron contrast ratio (CR) and normalized volume (nVol). Left-side NM nVol was larger in all groups. PD had lower NM CR and nVol in ventral-caudal SNc, whereas iron increased in lateral, medial-rostral, and caudal SNc. The SNc NM CR reduction was associated with psychiatric symptoms. LC CR and nVol discriminated better among subgroups: LRRK2-PD had similar LC NM CR and nVol as that of controls, and larger LC NM nVol and RN iron CR than iPD. PD showed higher iron SNc nVol than controls, especially among LRRK2-PD. ROC analyses showed an AUC.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Automatic segmentation and quantification of Nigrosome-1 neuromelanin and iron in MRI: A candidate biomarker for parkinson's disease

  • Ariz Galilea, Mikel
  • Martínez, Martín
  • Álvarez, Ignacio
  • Fernández Seara, María Asunción
  • Castellanos, Gabriel
  • Catalonian Neuroimaging Parkinson's Disease Consortium
  • Pastor, Pau
  • Pastor, María A.
  • Ortiz de Solórzano, Carlos
Background: There is a lack of automated tools for the segmentation and quantification of neuromelanin (NM) and iron in the nigrosome-1 (N1). Existing tools evaluate the N1 sign, i.e., the presence or absence of the ‘swallow-tail’ in iron-sensitive MRI, or globally analyze the MRI signal in an area containing the N1, without providing a volumetric delineation. Purpose: Present an automated method to segment the N1 and quantify differences in N1's NM and iron content between Parkinson's disease (PD) patients and healthy controls (HCs). Study whether N1 degeneration is clinically related to PD and could be used as a biomarker of the disease. Study Type: Prospective. Subjects: Seventy-one PD (65.3 ± 10.3 years old, 34 female/37 male); 30 HC (62.7 ± 7.8 years old, 17 female/13 male). Field Strength/Sequence: 3 T Anatomical T1-weighted MPRAGE, NM-MRI T1-weighted gradient with magnetization transfer, susceptibility-weighted imaging (SWI). Assessment: N1 was automatically segmented in SWI images using a multi-image atlas, populated with healthy N1 structures manually annotated by a neurologist. Relative NM and iron content were quantified and their diagnostic performance assessed and compared with the substantia nigra pars compacta (SNc). The association between image parameters and clinically relevant variables was studied. Statistical Tests: Nonparametric tests were used (Mann-Whitney's U, chi-square, and Friedman tests) at P = 0.05. Results: N1's relative NM content decreased and relative iron content increased in PD patients compared with HCs (NM-CRHC = 22.55 ± 1.49; NM-CRPD = 19.79 ± 1.92; NM-nVolHC = 2.69 × 10-5 ± 1.02 × 10-5; NM-nVolPD = 1.18 × 10-5 ± 0.96 × 10−5; Iron-CRHC = 10.51 ± 2.64; Iron-CRPD = 19.35 ± 7.88; Iron-nVolHC = 0.72 × 10-5 ± 0.81 × 10-5; Iron-nVolPD = 2.82 × 10−5 ± 2.04 × 10−5). Binary logistic regression analyses combining N1 and SNc image parameters yielded a top AUC = 0.955. Significant correlation was found between most N1 parameters and both disease duration (ρNM-CR = -0.31; ρiron-CR = 0.43; ρiron-nVol = 0.46) and the motor status ρNM-nVol = -0.27; ρiron-CR = 0.33; ρiron-nVol = 0.28), suggesting NM reduction along with iron accumulation in N1 as the disease progresses. Data Conclusion: This method provides a fully automatic N1 segmentation, and the analyses performed reveal that N1 relative NM and iron quantification improves diagnostic performance and suggest a relative NM reduction along with a relative iron accumulation in N1 as the disease progresses. Evidence Level: 1. Technical Efficacy: Stage 1., The authors would like to thank all the subjects who participated in this study. This work was supported by Instituto de Salud Carlos III (ISCIII) and European Union NextGenerationEU/PRTR (grant number PMP22/00100) and by FEDER and the Spanish Ministry of Science and Innovation and Universities MCIN/AEI (10.13039/501100011033) (grant numbers PDI2021-122409OB-C22, RTI2018-094494-B-C22, and TED2021-131300B-I00 [C.O.S] and SAF2016-81016-R [M.A.P]). The funders had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data and the final responsibility to submit for publication.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Brainstem neuromelanin and iron MRI reveals a precise signature for idiopathic and LRRK2 Parkinson's disease

  • Martínez, Martín
  • Ariz Galilea, Mikel
  • Álvarez, Ignacio
  • Castellanos, Gabriel
  • Aguilar, Miguel
  • Hernández-Vara, Jorge
  • Caballol, Núria
  • Garrido, Alicia
  • Bayés, Àngels
  • Vilas, Dolores
  • Martí, María J.
  • Catalonian Neuroimaging Parkinson's Disease Consortium
  • Pastor, Pau
  • Ortiz de Solórzano, Carlos
  • Pastor, María A.
Neuromelanin (NM) loss in substantia nigra pars compacta (SNc) and locus coeruleus (LC) reflects neuronal death in Parkinson’s disease (PD). Since genetically-determined PD shows varied clinical expressivity, we wanted to accurately quantify and locate brainstem NM and iron, to discover whether specific MRI patterns are linked to Leucine-rich repeat kinase 2 G2019S PD (LRRK2-PD) or idiopathic Parkinson’s disease (iPD). A 3D automated MRI atlas-based segmentation pipeline (3D-ABSP) for NM/iron-sensitive MRI images topographically characterized the SNc, LC, and red nucleus (RN) neuronal loss and calculated NM/iron contrast ratio (CR) and normalized volume (nVol). Left-side NM nVol was larger in all groups. PD had lower NM CR and nVol in ventral-caudal SNc, whereas iron increased in lateral, medial-rostral, and caudal SNc. The SNc NM CR reduction was associated with psychiatric symptoms. LC CR and nVol discriminated better among subgroups: LRRK2-PD had similar LC NM CR and nVol as that of controls, and larger LC NM nVol and RN iron CR than iPD. PD showed higher iron SNc nVol than controls, especially among LRRK2-PD. ROC analyses showed an AUC > 0.92 for most pairwise subgroup comparisons, with SNc NM being the best discriminator between HC and PD. NM measures maintained their discriminator power considering the subgroup of PD patients with less than 5 years of disease duration. The SNc iron CR and nVol increase was associated with longer disease duration in PD patients. The 3D-ABSP sensitively identified NM and iron MRI patterns strongly correlated with phenotypic PD features., The authors wish to thank all the participants of the study. SAF2016-81016-R (M.A.P) and RTI2018-094494-B-C22 (C.O.S) are funded by MCIN/AEI/10.13039/501100011033/ and FEDER grants.